8.7

CVE-2023-53734: dawa-pharma-1.0 - SQL Injection via Email Parameter

Deferred
Published 04-12-2025Last modified 07-04-2026

Vulnerability summary

CVE-2023-53734 is a high (CVSS 8.7) SQL Injection vulnerability in mayurik dawa-pharma. EPSS estimates a 0.53% chance of exploitation in the next 30 days, higher than 43.9% of scored vulnerabilities. 1 public exploit is recorded.

Overall risk
45/100
0100
Medium · default modelHow is this calculated?
CVSS score
8.7/10
010
High · v4.0 (CVE.org)
EPSS score
0.53%
0%100%
Low · 0.00 pp in 30 days
KEVNot listedNot listed by any tracked catalog.
RansomwareNot flaggedNo ransomware use recorded.
Public exploits1exploit-database

Timeline

  1. 04-12-2025
    PublishedVulnerability first disclosed.
  2. 07-04-2026
    Last modifiedVulnerability information updated.

Description

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

CVSS metrics

2 scores · 2 sources · 1 version

EPSS trend

Probability

0.53%

Chance of exploitation in the next 30 days

Percentile

44%

Versus all other CVEs

30-day change

No change 0.00 pp

From 0.53% on 22-09-2026

22-09-202622-10-2026

Known exploited

Compare KEV catalogs
CISA KEV

Not in the CISA KEV catalog.

ENISA CNW

Not in the ENISA CNW catalog.

CIRCL

Not in the CIRCL catalog.

Public exploits

1 found
  • exploit-databasephpUnverified

    dawa-pharma 1.0-2022 - Multiple-SQLi

    Maturity: poc

Weaknesses

CWE · root cause

Affected systems

Mayurik1 product

1 vendor · 1 product

References

5 links